ArticleThe ultrasound journal2025
Intrarenal venous flow patterns and their association with successful fluid removal in critically ill patients: a prospective observational exploratory study.
Article in The ultrasound journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06216119 (Intrarenal Venous Flow Change During Fluid Removal in Critically Ill Patients), which is not on this map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Intrarenal Venous Flow Change During Fluid Removal in Critically Ill Patients: A Prospective Exploratory Study
Who cites it
1 citing paper in PubMed.
- VExUS versus CVP for assessing venous congestion: oasis or mirage?Critical care (London, England) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundDetermining the optimal timing for fluid removal in critically ill patients remains a challenge. This study evaluated the utility of Doppler ultrasound, specifically intrarenal venous flow (IRVF) patterns and venous excess ultrasound (VExUS) scores, and their associations with fluid removal outcomes, hemodynamic parameters, and clinical endpoints.
methodsIn this prospective observational exploratory study, 52 intensive care unit (ICU) patients who underwent fluid removal were enrolled. Baseline IRVF patterns and VExUS scores were assessed, with follow-up evaluations performed daily for three days. The primary outcome was to evaluate whether IRVF patterns were associated with successful fluid removal, defined as achieving a negative fluid balance for at least two consecutive days. Secondary outcomes included associations with central venous pressure (CVP), NT-proBNP, cumulative fluid balance, and clinical outcomes.
resultsThirty-one patients (59.6%) achieved successful fluid removal. A discontinuous baseline IRVF pattern was independently associated with successful fluid removal (adjusted odds ratio 4.31, 95% CI 1.02-18.18; P = 0.047). This pattern demonstrated high sensitivity of 87.1% (95% CI 70.2-96.4), moderate specificity of 42.9% (95% CI 21.8-66.0), and accuracy of 69.2% (95% CI 54.9-81.3). VExUS scores grades 2-3 demonstrated high specificity of 85.7% (95% CI 63.7-97.0) but low sensitivity of 29.0% (95% CI 14.2-48.0), with an accuracy of 51.9% (95% CI 37.6-66.0). An improvement in the IRVF pattern was significantly correlated with a reduction in NT-proBNP levels (P = 0.048). However, neither IRVF patterns nor VExUS scores improvements were associated with changes in fluid balance, CVP, or clinical outcomes such as 28-day mortality, ventilator-free days, or ICU length of stay.
conclusionsDiscontinuous IRVF patterns at baseline were significantly associated with fluid removal success, representing a physiologically based marker for deresuscitation readiness. More large-scale studies are warranted to validate these findings and explore long-term implications. Trial registration ClinicalTrials.gov identifier NCT06216119. Registered 22 January 2024, https://clinicaltrials.gov/study/NCT06216119.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.